Return to Faculty List

Faculty

Cope, Rebecca, J.

Associate Professor of Pharmacy PracticeVice-Chair, Division of Pharmacy PracticeAssistant Director, Office of International Affairs

Pharm.D., Albany College of Pharmacy and Health Sciences

Description

Dr. Rebecca Cope obtained her Doctor of Pharmacy degree from Albany College of Pharmacy and Health Sciences in Albany, NY. Her post-graduate training includes a PGY-1 residency at The Brooklyn Hospital Center in Brooklyn, NY, a PGY-2 residency in Underserved Care and Global Health at UPMC in Pittsburgh, PA, and obtaining a Master of Public Health degree from Long Island University. She is certified by New York State to practice collaborative drug therapy management and maintains a clinical practice as a Board Certified Ambulatory Care Pharmacist at The Brooklyn Hospital Center. In addition to her academic and clinical roles at LIU Pharmacy, Dr. Cope serves as the Assistant Director for the Office of International Affairs where she provides administrative support for pharmacy students participating in international rotations and related College initiatives. Her research focuses on the pharmacists’ role as the medication expert in ambulatory care settings, both in the United States and abroad.

Specialties

Ambulatory Care, Public Health

Publications

  • Gim S, Cope R, Maddox K, Johnson J, Buffa T, Conteh T. (2022) Taking a Stand Against Counterfeit Drugs in Resource Poor Settings. In: Jonkman L, Karwa R eds. Case Studies in Global Health Pharmacy. Publication In-Progress.
  • Cope R, Sulkow H. Theory-Based Educational and Behavioral Interventions to Improve Oral Anticoagulant Adherence. In: Duncan LT, ed. Advances in Health and Disease. Volume 63. New York, NY: Nova Science Publishers, Inc; 2023:207-236.
  • Nguyen T, Wong E, Cope R. Evaluating the Efficacy and Pharmacoeconomics of Semaglutide and Tirzepatide in the Setting of Obesity. Am J Ther. 2023 Jul-Aug;30(4):e347-e352. doi: 10.1097/MJT.0000000000001643
  • Shtaynberg J, Gim S, Cope R, Maddox K, Delmonte K, O’Brocta R, Tackes C. Pharmacy Intern Involvement in COVID-19 Immunization Practices in New York State. J Pharm Pract. 2023 Mar 21. Online ahead of print. https://doi.org/10.1177/08971900231164748
  • Wong E, Cope R, Dima L, Nguyen T. Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus. Am J Ther. Jan-Feb 2023;30(1):e26-e35. doi: 10.1097/MJT.0000000000001588
  • Cope K, DeMicco J, Salib J, Mina M, Yakoub P, Daoud K, Cope R. Three Year Retention Rates with Office-Based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice. J Addict Med. 2022 Aug 1. doi: 10.1097/ADM.0000000000001009. Online ahead of print
  • Khaimova R, Fischetti B, Cope R, Berkowitz L, Bakshi A. Serological response with Heplisav-B® in prior Hepatitis B vaccine non-responders living with HIV. Vaccine. 2021 Oct 22;39(44):6529- 6534. doi: 10.1016/j.vaccine.2021.09.050. Epub 2021 Sep 30
  • Hasan MJ, Bachar SC, Rabbani R, Hosen MS, Cope RJ, Gim S. Evolution of Pharmacy Practice and Direct Patient Care Roles for Pharmacists in Bangladesh. J Am Coll Clin Pharm. 2021;4:718- 722. doi: 10.1002/jac5.1429
  • Cope RJ, Fischetti B, Eladghm N, Elaskandrany M, Karam N. Outpatient Management of Chronic Vitamin K Antagonist Therapy at a Pharmacist-Run Anticoagulation Clinic during the COVID-19 Pandemic. J Thromb Thrombolysis. 2021 Oct;52(3):754-758. doi: 10.1007/s11239- 021-02410-w. Epub 2021 Mar 6
  • Crowe SJ, Karwa R, Schellhase EM, Miller ML, Abrons JP, Alsharif NZ, Andrade C, Cope RJ, Dornblaser EK, Hachey D, Holm MR, Jonkman L, Lukas S, Malhotra JV, Njuguna B, Pekny CR, Prescott GM, Ryan M, Steeb DR, Tran DN. American College of Clinical Pharmacy Global Health Practice and Research Network’s Opinion Paper: Pillars for Global Health Engagement and Key Engagement Strategies for Pharmacists. J Am Coll Clin Pharm. 2020;3:1097-1112. doi: 10.1002/jac5.1232
  • Eneh P, Steeb DR, Cope RJ, Gim S, Northrop EF, Brearley AM, Okoro O. Students’ Perceptions of Global Health Competencies in the Doctor of Pharmacy (PharmD) Curriculum. Current Pharm Teach Learn. 2020 May;12(5): 531-538
  • Cope RJ, Fischetti B, Kavangh R, Lepa T, Sorbera M. Safety and Efficacy of Weight-Loss Pharmacotherapy in Persons Living with HIV: A Review of the Literature and Potential Drug- Drug Interactions with Antiretroviral Therapy. Pharmacotherapy. 2019 Dec;39(12): 1204-1215
  • Cope RJ. Formulary Considerations: Evaluating the Use of Direct Oral Anticoagulant Reversal Agents in Health-Systems. Pharmacy Times Continuing Education. 2019 Jan 31. [PharmacyTimes.org]
  • Gallipani A, Cope RJ, Fischetti B, Abraham S, Ankireddypalli A. Prescriber Attitudes Toward Implementation of Pharmacogenomic Testing in a Family Medicine Residency Program. PRiMER. 2018;2:22
  • Cope RJ, Jonkman L, Quach K, Ahlborg J, Connor S. Transitions of Care: Medication related barriers identified by low socioeconomic patients of a federally qualified health center following hospital discharge. RSAP. 2018 Jan;14(1):26-30
  • Sorbera M, Friedman M, Cope RJ. New and Emerging Evidence on the Use of Second- Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment. J Pharm Pract. 2017 Jun;30(3):359-365
  • Cope RJ, Glowa T, Faulds S, McMahon D, Prasad R. Treating Hepatitis C in a Ryan-White Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era? AIDS Patient Care STDS. 2016 Feb;30(2):51-5
  • Cope RJ, Berkowitz L, Arcebido R, Trustman N, Yeh J, Cha A. Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-Morbidities. AIDS Patient Care and STDS. 2015 Aug;29(8):445-53
  • Cope RJ, Pickering A, Glowa T, Faulds S, Veldkamp P, Prasad R. Majority of HIV/HCV Patients Need to Switch ART to Accommodate Simeprevir. AIDS Patient Care and STDs. 2015 Jul;29(7): 379-83

Lectures and Presentations

Lectures

  • Cope R. How Does Change Happen? Introduction to Social and Behavioral Theory for Pharmacists. Keynote Lecture and ACPE-accredited CE program presented at: Royal Counties 18th Annual New York City Regional Pharmacy Residency Conference, June 15, 2023; New York, NY.
  • Cope R. How Does Change Happen? Introduction to Social and Behavioral Theory for Pharmacists. ACPE-accredited CE program presented at: Pharmacists Society of the State of New York, May 17, 2023; Plainview, NY.
  • Gim S, Cope R. Using Book Clubs to Start Crucial Conversations Related to Diversity, Equity, Inclusion, & Anti-Racism. AACP Annual Meeting; July 24-27, 2022; Dallas, TX.
  • Cope R. How Does Change Happen? Introduction to Social and Behavioral Theory for Pharmacists. Pfizer Continuing Education Series; June 23, 2022
  • Cope R (slides prepared by Bhatt SH). Novel Reversal Agents to Safely and Effectively Treat Direct Oral Anticoagulant Bleeding: Education for the Health-System Pharmacist. Minnesota Society of Health-System Pharmacists; May 27, 2021.
  • Cope R (slides prepared by Bhatt SH). Novel Reversal Agents to Safely and Effectively Treat Direct Oral Anticoagulant Bleeding: Education for the Health-System Pharmacist. Utah Society of Health-Systems Pharmacists; May 19, 2021.
  • Cope R (slides prepared by Bhatt SH). Novel Reversal Agents to Safely and Effectively Treat Direct Oral Anticoagulant Bleeding: Education for the Health-System Pharmacist. Richmond Pharmacists Association; May 17, 2021.
  • Cope R (slides prepared by Bhatt SH). Novel Reversal Agents to Safely and Effectively Treat Direct Oral Anticoagulant Bleeding: Education for the Health-System Pharmacist. Texas Society of Health-Systems Pharmacists; May 6, 2021.
  • Cope R, Gim S. COVID-19 Testing and Vaccinations. LIU Pharmacy Continuing Education Program, Brooklyn, NY; Jun 8, 2020; Brooklyn, NY.
  • Cope R (slides prepared by Kalus JS).The Role of The Health System Pharmacist in Safely and Effectively Treating Direct Oral Anticoagulants Bleeding with Novel Reversal Agents. New Jersey Pharmacist Association; Sep 26, 2019; Hammonton, NJ.
  • Cope R (slides prepared by Kalus JS).The Role of The Health System Pharmacist in Safely and Effectively Treating Direct Oral Anticoagulants Bleeding with Novel Reversal Agents. Royal Counties Chapter of New York State Council of Health Systems Pharmacists; Sep 5, 2019; Brooklyn, NY.
  • Cope R (slides prepared by Kalus JS).The Role of The Health System Pharmacist in Safely and Effectively Treating Direct Oral Anticoagulants Bleeding with Novel Reversal Agents. Washington Metropolitan Society of Health-System Pharmacists; Aug 29, 2019; Washington DC.
  • Cope R. In a Bind:  Reversal Agents for Direct Oral Anticoagulants.Royal Counties Chapter of New York State Council of Health Systems Pharmacists; Nov 6, 2018; Brooklyn, NY.
  • Cope R. COPD Evidence-Based Pharmacotherapy Update:  2018 Gold Guidelines for Pharmacists.LIU Pharmacy Continuing Education Program; May 6, 2018; Brooklyn, NY.
  • Cope R. COPD Evidence-Based Pharmacotherapy Update:  2017 Gold Guidelines for Pharmacists.Royal Counties Chapter of New York State Council of Health Systems Pharmacists; Feb 26, 2018; Brooklyn, NY.
  • Cope R. In a Bind:  Reversal Agents for Direct Oral Anticoagulants.New York State Chapter of the American College of Clinical Pharmacy Annual Conference; Nov 11, 2016; Rochester, NY.
  • Cope R, Cha A. Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist Collaboration on HIV Patient Co-morbidities. New York State Department of Health AIDS Institute, Quality of Care Clinical Advisory Committee Meeting; Mar 10, 2016; New York, NY.
  • Connor S, Cope R, Lyons A, Malek S. Clinical Trials in Developing Countries – Beneficial or Exploitation? Global Health Equity Lecture Series, University of Pittsburgh; Mar 2015; Pittsburgh, PA.
  • Cope R. Concentrating on U-500 Regular Insulin. University of Pittsburgh Medical Center Continuing Education Program; Jan 2015; Pittsburgh, PA.

Poster Presentations

  • Badran H, Kim KY, Cope R, Sarsour M, Quinn R, Sasson E. Appropriateness of Apixaban Dosing Before and After Implementation of an Order Set in an Inpatient Setting at a Community Teaching Hospital. Poster presented at: American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting; Dec 4-8, 2022, Las Vegas, NV.

  • Fidler B, Gim S, Cope R, Alexander A, Lonie J, Hodurski T, Novatt J, Roitman J. Bridging the gaps between diversity, equity, inclusion, anti-racism and education at an urban College of Pharmacy. Poster presented at AACP Annual Meeting; July 24-27, 2022, Dallas, TX.
  • Lim A, Sasson E, Cope R, Mondiello T, Quinn R. Retrospective Analysis of Rivaroxaban Prescribing in an Inpatient Setting at a Community Teaching Hospital. Poster presented at: American Society of Health-System Pharmacists (ASHP) Midyear Virtual Clinical Meeting; Dec 5-9, 2021.
  • Cope K, DeMicco J, Salib J, Mina M, Yakoub P, Daoud K, Cope R. Three Year Retention Rates with Office-Based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice. Poster presented at: ASHP Midyear Virtual Clinical Meeting; Dec 5-9, 2021.
  • Gim S, Shtaynberg J, Cope R. Pharmacy Intern Involvement in COVID-19 Immunization Practices in New York State. Poster Presented at: American Public Health Association (APHA) Annual Meeting; Oct 24-26, 2021; Denver, CO.
  • Karam N, Njeim N, Gim S, Cope R. Student-Led Diversity Book Clubs to Promote Student Understanding and Awareness of Structural Racism. Poster Presented at: American Association of Colleges of Pharmacy (AACP) Virtual Annual Meeting; July 19-22, 2021.
  • Wong E, Villegas S, Zerilli T, Cope R, Novatt J, Alexander A, Bova J.  Doctor of Pharmacy Program Adaptations Amidst a Pandemic in NYC: Lessons Learned. Poster Presented at: AACP Virtual Annual Meeting; July 19-22, 2021.
  • Morgan R, Gamaleldin A, Cope R, Alexander A. Impact of Student Pharmacists’ Education on Medical Students’ Immunization Knowledge and Perceptions of Pharmacists in an Interprofessional Setting. Poster presented at: ASHP Midyear Virtual Clinical Meeting; Dec 6-10, 2020.
  • Cope R, Fischetti B, Eladghm N, Elaskandrany M, Karam N. Outpatient Management of Chronic Vitamin K Antagonist Therapy at a Pharmacist-Run Anticoagulation Clinic during the COVID-19 Pandemic. Poster presented at: ASHP Midyear Virtual Clinical Meeting; Dec 6-10, 2020.
  • Narain L, Quinn R, Cope R, Dous E, Geris A. Safety and Efficacy of Anticoagulation Therapy in Non-Valvular Atrial Fibrillation Patients on Hemodialysis. Poster presented at: ASHP Midyear Virtual Clinical Meeting; Dec 6-10, 2020.
  • Greco N, Fischetti B, Cope, R. Medication Use Evaluation of Outpatient Prescribing of Direct Oral Anticoagulants. Poster presented at: ASHP Midyear Clinical Meeting; Dec 8-12, 2019; Las Vegas, NV.
  • O’Neal H, Cope R, Fischetti B. Antiretroviral Therapy Simplification to Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Presence of M184V mutation. Poster presented at: ASHP Midyear Clinical Meeting; Dec 8-12, 2019; Las Vegas, NV.
  • Slaby M, Fischetti B, Cope R. Appropriateness of Outpatient Use of Dual and Triple Antithrombotic Therapies in Patients with Atrial Fibrillation. Poster presented at: ASHP Midyear Clinical Meeting; Dec 8-12, 2019; Las Vegas, NV.
  • Saif H, Clouser A, Cope R, Gim S. Importance of Medical Mission Team Preparedness in Striving for Optimal Patient Disease Management in Indigenous Regions of Guyana. Poster presented at: ASHP Midyear Clinical Meeting; Dec 8-12, 2019; Las Vegas, NV.
  • Eldeeb F, Samaan D, Sulkow H, Fischetti B, Cope R. Evaluation of Uncontrolled Hypertension in an Outpatient Anticoagulation Clinic. Poster presented at: ASHP Midyear Clinical Meeting; Dec 8-12, 2019; Las Vegas, NV.
  • Prescott G, Cope R, Holm M, Crowe S. Global Health PRN History. Poster presented at: American College of Clinical Pharmacists (ACCP) Annual Meeting; Oct 26, 2019; New York, NY.
  • Bazarova T, Salib J, Cope R. Lack of Real-World Use of Spironolactone for Resistant Hypertension. Poster presented at: ACCP Annual Meeting; Oct 26, 2019; New York, NY.
  • Sulkow H, Chaudhry F, Narain L, Hughes J, Cope R. Safety and Efficacy of GLP-1 Receptor Agonists in Patients with Low-to-Normal BMI. Poster presented at: ACCP Annual Meeting; Oct 26, 2019; New York, NY.
  • Gim S, Cope R. Pharmacy Practice Without Borders: Development of International Pharmacy Practice Experiences for Future Global Pharmacists. Poster presented at: AACP Annual Meeting; July 13-16, 2019; Chicago, IL.
  • Eneh P, Steeb D, Cope R, Gim S, Okoro O. Students’ Perceptions of Global Health Competencies in the Doctor of Pharmacy (PharmD) Program. Poster presented at: AACP Annual Meeting; July 13-16, 2019; Chicago, IL.
  • Cope R, Gim S. Inter-Rater Reliability of Four Reflection Rubrics in an Elective Global Health Course. Poster presented at: AACP Annual Meeting; July 13-16, 2019; Chicago, IL.
  • Clouser A, Cope R, Grossman S, YauLin J. Impact of an interactive Top 300 Drug game on a pre-APPE competency exam. Poster presented at: AACP Annual Meeting; July 13-16, 2019; Chicago, IL.
  • Eneh P, Steeb D, Cope R, Gim S, Okoro O. Students’ Perceptions of Global Health Competencies in the Doctor of Pharmacy (PharmD) Program. Poster presented at: ACCP Annual Meeting; Oct 20-23, 2018; Seattle, WA.
  • Bulku S, Cope R. Primary Reason for Discontinuation of Sulfonylureas and Impact on Blood Glucose Control in Type 2 Diabetes Patients Following in Three Outpatient Pharmacotherapy Clinics. Poster presented at: ASHP Midyear Clinical Meeting; Dec 3-7, 2017; Orlando, FL.
  • Paone S, Cope R. GLP-1 Utilization Rates Over Time in an Urban, Community Hospital. Poster presented at: ASHP Midyear Clinical Meeting; Dec 3-7, 2017; Orlando, FL.
  • Lau K, McIver L, Cope R. Pre-Diabetes Cardiovascular Risk Reduction Survey:  Patient Understanding and Treatment Preference. Poster presented at: ASHP Midyear Clinical Meeting; Dec 3-7, 2017; Orlando, FL.
  • Gallipani A, Abraham S, Ankireddypalli A, Luteran B, Cope R. Prescriber Attitudes Towards Implementation of Pharmacogenomic Testing in the Primary Care Setting. Poster presented at: Society of Teachers of Family Medicine Annual Conference; May 2017; San Diego, CA.
  • McIver L, Abraham S, Ankireddypalli A, Luteran B, Cope R. Attitudes and Perceptions amongst Physicians regarding Pre-Exposure Prophylaxis (PrEP) for High Risk Patients in the Primary Care Setting. Poster presented at Society of Teachers of Family Medicine Annual Conference; May 2017; San Diego, CA.
  • Bazarova T, Cope R. Preferred First-line Add-on Therapy to Metformin in Non-Insulin Dependent Diabetic Patients in an Outpatient Urban Setting. Poster presented at: ASHP Midyear Clinical Meeting; Dec 2016; Las Vegas, NV.
  • Cope R, Glowa T, Faulds S, McMahon D, Prasad RK. Treating Hepatitis C in a Ryan White-Funded HIV Clinic:  Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era? Poster presented at: Society of Teachers of Family Medicine (STFM) Annual Spring Conference; May 2016; Minneapolis, MN.
  • Cope R, Jonkman L, Connor S, Meyer M. Evaluation of Asthma Knowledge following Implementation of an Asthma Treatment Program in a Remote Community of Honduras. Poster presented at: American College of Clinical Pharmacy; Oct 2015; San Francisco, CA.
  • Cope R, Jonkman L, Connor S, Meyer M. Measuring Asthma Knowledge and Medication Adherence in a Remote Community of Honduras. Poster presented at: Conference on the Science of Medication Adherence; June 2015; Pittsburgh, PA.
  • Pickering A, Cope R, Glowa T, Faulds S, Veldkamp P, Prasad R. Majority of HIV/HCV Co-infected Patients Require Antiretroviral Therapy Switch Prior to Use of Simeprevir. Poster presented at:  HIV & Liver Disease Conference; Sep 2014; Moran, WY.

Research Platform Presentations

  • Arnold R, Cope R. Pharmacist-Driven Medication Management for Cardiovascular Risk Reduction Therapies in Patients with Type 2 Diabetes. Platform presentation at: Eastern States Residency Conference, May 2023; Hershey, PA. Samuel P, Lazarevskiy P, Cassidy K, Cope R. Population Changes in a Warfarin Anticoagulation Clinic Following Introduction of Direct Oral Anticoagulants. Platform presentation at: NYSCHP Annual Assembly, April 2023; Saratoga Springs, NY.
  • Gamaleldin A, Cope R. Prescriber Management of Direct Oral Anticoagulants during the Perioperative Period. Platform presentation at: New York City Residency Conference, June 2022; Brooklyn, NY. Sarsour M, Cope R, Quinn R, Sasson E, Badran H, Kim K. Appropriateness of Apixaban Dosing Before and After Implementation of Order Set in an Inpatient Setting at a Community Teaching Hospital. Platform presentation at: New York City Residency Conference, June 2022; Brooklyn, NY.
  • Sulkow H, Fischetti B, Cope R. Implementation of a Hypertension Management Program Within an Outpatient Anticoagulation Clinic. Platform presentation at: New York City Residency Conference; June 2020; Brooklyn, NY.
  • Khaimova R, Cope R, Fischetti B. Efficacy of Heplislav-B in Patients Living with Human Immunodeficiency Virus. Platform presentation at: New York City Residency Conference; June 2020; Brooklyn, NY.
  • Bazarova T, Salib J, Cope R. Lack of Real-World Use of Spironolactone for Resistant Hypertension. Platform presentation at: New York City Residency Conference; June 2019; Brooklyn, NY.
  • Sulkow H, Narain L, Chaudhry F, Hughes J, Cope R. Safety and Efficacy of GLP-1 Receptor Agonists in Patients with Low-to-Normal BMI. Platform presentation at: Eastern States Residency Conference; April 2019; Hershey, PA.
  • Bazarova T, Cope R. Identifying the Gaps in Guidelines: How many patients on appropriate intensity statin therapy should have qualified for additional statin lipid lowering treatment to prevent ASCVD? Platform presentation at: NYSCHP Annual Assembly; May 2018; Saratoga Springs, NY.Grossman K, Besignano-Long A, Tran V, Cope R. Evaluation of Pharmacist Intervention on the Appropriate Prescribing of Direct Acting Oral Anticoagulants. Platform presentation at: Eastern States Residency Conference; May 2017; Hershey, PA.
  • Besignano-Long A, Cha A, Kelly P, Cope R. Evaluating the Clinical Significance of Dolutegravir and Metformin Co-Administration in HIV Patients. Platform presentation at: NYSCHP Annual Assembly; May 2016; Saratoga Springs, NY.
  • Pickering A, Cope R, Glowa T, Faulds S, Veldkamp P, Prasad R.Majority of HIV/HCV Co-infected Patients Require Antiretroviral Therapy Switch Prior to Use of Direct-Acting Antiviral Agents.
  • Platform presentation at: 22nd Annual Conference for Retroviruses and Opportunistic Infections; Feb 2015; Seattle, WA. Cope R, Cha A, Berkowitz L, Arcebido R, Yeh J. Effects of an Interdisciplinary Practice Model on HIV Patient Outcomes. Platform presentation at: Eastern States Residency Conference; May 2014; Hershey, PA.
  • Messia J, Aiello P, Cope R, Phillips M. Starting and Sustaining Peer Advising on Your Campus – 3 Case Studies. Platform presentation at: National Academic Advising Association Region 1 Conference; Feb 2011.

Honors/Awards

  • (2021) American Public Health Association Pharmacy Special Interest Group Professional Poster Award
  • (2021) David Newton Excellence in Teaching Award
  • (2015) American Association of Colleges of Pharmacy Walmart Scholar Recipient
  • (2014) New York Society of Health-Systems Pharmacists and Education Foundation Award

Professional Affiliations

  • Member, American College of Clinical Pharmacy
  • Member, American Association of Colleges of Pharmacy
  • Member, Anticoagulation Forum
  • Member, New York State Council of Health-System Pharmacists
  • Member, Rho Chi Honor Society